Quan Xie (Buthus martensii) Pharmacology — The ‘Whole Scorpion’ Behind Anti-Spasmodic Pills, Trigeminal-Neuralgia Topicals, and Modern Nav1.7 Pain Research

In the cluttered drug cabinet of an old Hong Kong dit-da clinic — where bottles of Zheng Gu Shui sit beside dusty boxes of Die Da Wan and a glass jar of dried, salt-grey arthropods that look unsettlingly like what they are — there is a small, square paper box almost no tourist asks about. The label reads 全蝎 (Quán Xiē) — Buthus martensii Karsch, dried whole scorpion. Open it and you will find perhaps thirty curled, pale-yellow scorpions, each two to six centimetres long, tail intact, claws folded inward, faintly salted, faintly fishy.

Quan Xie is the most famous animal drug in Chinese pharmacology after the more controversial gallbladder and horn substances, and unlike those it is still in routine, legal clinical use across Greater China. It does not appear in many topical medicated oils — for reasons we will get to, peptide drugs do not cross intact stratum corneum well — but it is the silent oral companion to dit-da liniments, sitting inside formulas like Da Huo Luo Dan (大活络丹), Zai Zao Wan (再造丸), Die Da Wan (跌打丸), Zhi Jing San (止痉散), and the trigeminal-neuralgia and stubborn-migraine tinctures that Lingnan and northern-Chinese clinicians reach for when ordinary ingredients have failed.

This article unpacks what is actually doing the work inside that paper box: the venom peptide chemistry, the surprisingly modern pain pharmacology, the formulations Quan Xie anchors, and the safety boundary that every serious user — clinician or patient — has to know.

1. Zoology, provenance, and processing

The Chinese medicinal scorpion is Mesobuthus martensii (Karsch, 1879), still routinely catalogued under its older binomial Buthus martensii, family Buthidae. It is a temperate-zone scorpion — not the larger tropical species used in cuisine — distributed across northern China, Korea, and Mongolia. The medicinally graded supply comes overwhelmingly from Shandong (Yiyuan and Linyi counties), Henan, Hebei, Liaoning, and Anhui, with Shandong’s Yi-Meng mountain district considered the gold standard. Wild populations have been heavily depleted, and most pharmacy-grade material now comes from regulated farms, which sell the live animals to processing co-operatives in early summer.

The classical processing protocol matters more than most users realise. Live scorpions are starved for two days to clear their gut, then plunged into one of two baths:

Plain Quan Xie (淡全蝎) — boiling water only. Higher residual venom load; preferred in some northern hospital pharmacies for the strongest anti-spasmodic effect.
Salt Quan Xie (咸全蝎 / 盐全蝎) — boiling 5–10 % brine. The standard commercial product. Salt both kills the animal humanely fast and preserves the body for long shelf life, but it adds an inert salt load (sometimes 30–40 % of finished weight) that unscrupulous traders amplify by repeated brine soaking — see the adulteration section below.

After boiling, scorpions are sun-dried until brittle. The Chinese Pharmacopoeia 2020 specifies the whole, head-and-tail-intact dried body as the legitimate drug; broken pieces, tail-only (“Xie Wei / 蝎尾”), and pre-powdered material are all acceptable but priced and dosed differently because the venom load is concentrated in the terminal segment of the tail (telson) containing the venom apparatus.

2. What is actually inside a dried scorpion

Modern proteomics and cDNA library work — much of it from Chinese, Belgian, and German groups since the early 2000s — has decoded the venom of B. martensii in remarkable detail. Quan Xie contains four overlapping families of bioactive material:

2.1 Long-chain sodium-channel toxins (the headline actives)

These are 60–76-residue peptides folded by three or four disulphide bridges, the classical scorpion α- and β-toxins. Cao et al.’s 2002 cDNA survey identified at least 51 long-chain Na⁺-channel-related peptides, including 34 α-toxin family members, ten depressant insect toxins, and several β-like toxins. The clinically interesting ones in pain research include:

BmK I — α-like toxin, modulates Nav1.7 inactivation.
BmK AS and BmK AS-1 — analgesic α-toxins that act on the ryanodine receptor rather than Nav directly, with non-narcotic analgesia comparable in some inflammation models to morphine.
BmK AGAP (analgesic-antitumor peptide) — perhaps the most studied molecule, with both analgesic activity (Nav1.7 modulation) and dose-dependent inhibition of glioma and breast-cancer cell proliferation.
Makatoxin-3 — a thermostable Nav1.7 agonist characterised in 2022 that elicits non-narcotic analgesia in inflammatory pain models without the central reward circuitry that opioids touch.

2.2 Short-chain potassium- and chloride-channel toxins

These are smaller (28–40 residues, three disulphide bridges) and include defensins, BmKBTx, BmKK6, and the family of chlorotoxin-like peptides. The flagship here is BmK CT (Buthus martensii chlorotoxin) — homologous to the celebrated Leiurus chlorotoxin (CTX) used in glioma-imaging clinical trials. A purified, recombinant rBmK CTa inhibited glioma cell proliferation with an IC₅₀ of ~0.28 µM in in vitro studies, and ¹³¹I-labelled BmK CT has been investigated as a SPECT-imaging and radionuclide-therapy agent for malignant glioma at several Chinese teaching hospitals.

2.3 Anti-epileptic peptide (AEP) and analgesic-antitumour peptide (ANEP)

Mainland Chinese pharmacology textbooks single out two crude-fraction descriptors that predate the modern peptide names:

AEP (anti-epileptic peptide) — anticonvulsant activity comparable to diazepam in caffeine-, pentylenetetrazol-, and metrazol-induced seizure models; the molecular basis is now understood to be a mix of α-toxins suppressing aberrant Nav firing and short-chain peptides modulating GABAergic relay.
ANEP / scorpion analgesic-antitumour peptide — older umbrella term for what is now resolved into BmK AGAP, AGP-SYPU1/2, and related sequences.

2.4 Non-peptide constituents

Beyond the venom proteome, the dried whole body also contains trimethylamine and betaine (responsible for the faint fishy smell), lecithin, taurine, palmitic and stearic acids, free amino acids (especially glycine and glutamic acid), nucleosides (adenosine, inosine), and chitin from the exoskeleton. None of these is decisive on its own, but the amino-acid and nucleoside fraction may explain why an oral whole-scorpion decoction has a milder, broader pharmacology than a purified single peptide.

3. How it actually relieves pain and stops spasm

Pre-modern Chinese pharmacology classified Quan Xie as acrid, neutral, slightly toxic, entering the Liver channel, with four classical actions: extinguish wind and stop spasms (息风止痉), attack toxin and disperse nodules (攻毒散结), dredge collaterals and stop pain (通络止痛), and arrest convulsion (镇惊). Twenty-first-century pharmacology has matched each of those phrases to a molecular axis.

3.1 Nav1.7 — the “stop pain” pathway

Nav1.7 (encoded by SCN9A) is the voltage-gated sodium channel that gates nociceptor firing; humans with loss-of-function mutations are congenitally pain-insensitive, and the channel is now the central target of modern non-opioid analgesic development. BmK water extracts elicit analgesic effects exceeding morphine in CFA inflammatory pain models in mice, and the active fraction has been resolved to thermostable peptides (Makatoxin-3 and analogues) that bind site 4 of Nav1.7 and shift its activation threshold. For a clinician, this is the molecular reason Quan Xie is reached for in trigeminal neuralgia, post-herpetic neuralgia, stubborn unilateral migraine, and sciatica that has resisted ordinary herbal warming-and-dredging therapy.

3.2 Anticonvulsant and anti-epileptic action

AEP and related peptides suppress the high-frequency repetitive firing characteristic of focal seizures. The classical formulation Zhi Jing San (止痉散 — equal parts Quan Xie and Wu Gong) is still routinely prescribed in mainland Chinese hospitals as adjunctive therapy for tic disorders, post-stroke spasticity, and refractory paediatric convulsions, often alongside conventional antiepileptics.

3.3 Anti-thrombotic and fibrinolytic action

Crude scorpion extract has demonstrated antiplatelet, anticoagulant and pro-fibrinolytic activity in rabbit and rat models, mediated partly by short-chain peptides that interfere with thrombin generation. Clinically, this underwrites Quan Xie’s role in post-stroke hemiplegia recovery formulations like Zai Zao Wan and Hua Tuo Zai Zao Wan — the same class of patent medicines that elderly Hong Kong patients take orally while a family member rubs Wong To Yick or Zheng Gu Shui onto the affected limb topically.

3.4 Anti-tumour activity

BmK CT chlorotoxin-like peptides bind selectively to MMP-2 / chloride channels overexpressed on glioma and several other tumours, and BmK AGAP induces dose-dependent apoptosis in glioma and breast-cancer lines. This is not the topical-pain story, but it is part of why Chinese oncology-integrated centres still pay attention to whole-scorpion preparations.

4. Where Quan Xie actually appears in dit-da and medicated-oil practice

Be honest about this: Quan Xie is rarely a direct ingredient in over-the-counter topical medicated oils. The reason is straightforward biopharmaceutics — the active molecules are 4–8 kDa peptides that do not meaningfully cross the stratum corneum in a simple alcohol-and-camphor base. So when you read the ingredient list of Wong To Yick, Tiger Balm, Po Sum On, or Zheng Gu Shui, you will not see scorpion.

Where it does show up:

Oral patent pills taken alongside topical oil: Da Huo Luo Dan, Zai Zao Wan, Hua Tuo Zai Zao Wan, Tian Ma Wan, Die Da Wan (some formulations), Niu Huang Zhen Jing Wan. These are the systemic side of a treatment that pairs them with topical liniments for stroke recovery, severe migraine, or trigeminal pain.
Specialty medicated wines (药酒) for severe rheumatic pain: small-batch Lingnan and northern-Chinese formulae use Quan Xie 3–6 g per litre in a long ethanol extract, sometimes with Wu Gong, Bai Hua She, and Quan Chong, on the rationale that ethanol and prolonged maceration extract enough small-molecule and short-peptide content to give measurable benefit.
Pin-point trigeminal-neuralgia tinctures: Hospital-pharmacy preparations in mainland China sometimes use a Quan Xie + Tian Nan Xing + camphor liniment dabbed precisely on trigger points, again leveraging ethanol extraction.
DMSO-enhanced experimental topicals: A small modern research literature has investigated penetration enhancers (DMSO, propylene glycol, microneedle arrays) to make scorpion-derived peptides topically bioavailable for localised neuropathic pain. These are not yet OTC products.

So the practical reading is: if your dit-da practitioner adds Quan Xie, it is almost always as an oral pill or an internal decoction, working systemically while the medicated oil works peripherally on the same lesion.

5. Quality, grading, and the adulteration problem

Pharmacy-grade Quan Xie should be:

Whole-bodied, head-and-tail intact, two to six centimetres long, pale yellow-green to brownish, with the segmented metasoma clearly visible.
Faintly fishy and salty in smell, never musty or ammoniacal.
Brittle when snapped, with a hollow body cavity (the gut having been emptied during pre-processing).

The two persistent adulteration patterns to know about are:

Mud or starch injection into the body cavity to inflate weight. Reputable pharmacies break a sample scorpion to check for an empty interior.
Excess salt loading — repeated brine soaking that brings salt content to >40 % of finished weight. The Chinese Pharmacopoeia caps total ash at 10 % for properly processed material; serious herbal pharmacies test their batches.

Tail-only material (Xie Wei / 蝎尾) is more potent (the venom is concentrated there) and priced two to three times higher per gram; some traditional formulae specify it deliberately, and substituting whole-body for tail-only — or vice versa — quietly changes the dose curve.

6. Safety — the boundary every user must respect

Quan Xie is officially classified as a toxic herb (有毒) in the Chinese Pharmacopoeia. Sensible boundaries:

Decoction dose: 3–6 g of dried whole body, never long-term.
Powdered dose: 0.6–1 g, often divided.
Paediatric convulsion dose: as low as 60–90 mg, calculated by weight, under clinical supervision.
Pregnancy: absolute contraindication (uterine-stimulant, embryotoxic effects in animal data, and traditional contraindication unbroken for a thousand years).
Blood-deficient internal wind, yin-deficient hyperactive wind: classical contraindication, because Quan Xie’s acrid wind-extinguishing action can deplete fluids further.
Allergy: scorpion-protein allergy is real and not rare. Anaphylaxis has been reported, especially in patients with prior bee-venom or wasp-venom sensitisation. A first-time oral dose should be taken in a setting where allergic reaction can be managed.
Overdose: Hong Kong Medical Journal published a documented case of generalised involuntary limb twitching after ingestion of Mesobuthus martensii powder at higher than the labelled dose. Symptoms of overdose include numbness, paraesthesia, palpitations, dyspnoea, and in severe cases respiratory depression — the same Nav-channel pharmacology that gives the analgesic benefit becomes life-threatening at multiples of the therapeutic dose.

Topical use of an alcoholic Quan Xie tincture on broken skin can cause systemic absorption of small peptides and small-molecule constituents, so even external-use specialty preparations should be applied to intact skin, never on open dit-da abrasions.

7. Where the evidence ends

The pharmacology of Quan Xie is one of the most thoroughly mapped of any TCM animal drug — the BmK peptide literature alone runs into the hundreds of papers — and the modern Nav1.7 and chlorotoxin work has produced genuinely innovative drug-development leads. But the clinical evidence base for the whole-scorpion crude drug as it is actually used in dit-da and stroke-recovery practice remains uneven: most rigorous trials are on isolated peptides (Makatoxin-3, BmK AGAP, recombinant BmK CT) in tightly controlled animal models, not on the salt-boiled whole arthropod consumed orally as part of a multi-herb pill.

What you can confidently say is that Quan Xie is a legitimate, ancient, peptide-rich analgesic and anticonvulsant whose mechanism of action is now understood in molecular detail, whose place in the dit-da clinic is as an oral systemic adjunct to topical liniments rather than as a topical ingredient itself, and whose dose ceiling is narrow enough that lay self-prescription is a bad idea. If a practitioner reaches for it in your treatment plan, that is usually a sign your case is at the more difficult end of the pain or wind-stirring spectrum — not a routine choice.

The little salt-grey scorpion in the paper box on the shelf has, in the end, the same job it has had for a thousand years: when ordinary herbs are not enough, it goes in.